(16)In order to avoid unnecessary administrative and financial burdens for industry and competent authorities, a full in-depth evaluation of an application to renew the approval of an active substance or the authorisation of a biocidal product should be carried out only if the competent authority that was responsible for the initial evaluation decides that this is necessary on the basis of the available information.
◷
New version applies from 23/09/2013.
165 provisions change.
Later versions: 25/04/2014, 20/11/2019, 29/03/2021, 10/06/2021, 15/04/2022, 26/05/2024, 11/06/2024, 15/06/2026, 19/08/2026.
Recital 16 changes in this version: compare with the current text.